DJ Novavax Inc. Stock Underperforms Wednesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ slipped 2.44% to $9.21 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 0.08% to 26,130.20 and Dow Jones Industrial Average falling 0.21% to 53,463.88.
Novavax Inc. closed 23.06% short of its 52-week high of $11.97, which the company achieved on February 26th.
The stock underperformed when compared to some of its competitors Wednesday, as Johnson & Johnson $(JNJ)$ fell 1.15% to $270.00, Pfizer Inc. $(PFE)$ fell 0.95% to $28.30, and Merck & Co. Inc. $(MRK)$ fell 2.14% to $153.10.
Trading volume (3.5 M) remained 575,344 below its 50-day average volume of 4.1 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 26, 2026.